| Product NDC: | 0185-0032 |
| Proprietary Name: | Reserpine |
| Non Proprietary Name: | Reserpine |
| Active Ingredient(s): | .1 mg/1 & nbsp; Reserpine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0185-0032 |
| Labeler Name: | Eon Labs, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009838 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19880311 |
| Package NDC: | 0185-0032-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (0185-0032-10) |
| NDC Code | 0185-0032-10 |
| Proprietary Name | Reserpine |
| Package Description | 1000 TABLET in 1 BOTTLE (0185-0032-10) |
| Product NDC | 0185-0032 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Reserpine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19880311 |
| Marketing Category Name | NDA |
| Labeler Name | Eon Labs, Inc. |
| Substance Name | RESERPINE |
| Strength Number | .1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Catecholamine-depleting Sympatholytic [EPC],Decreased Sympathetic Activity [PE] |